The Odd Timing of the Final Rule on Samsung Biologics and Firing of Kim Dong-Yeon & Jang Ha-Sung
It was reported in numerous local Korean media today that the final decision by the regulators on the fate of Samsung Biologics Co., (207940...
353 Views
Samsung BioLogics Update
Recent developments in Samsung Biologics Co., (207940 KS)'s business have been mixed with a negative skew. First, partner Merck & Co Inc (MRK...
527 Views
Celltrion Inc Placement - Shorter Lockup Period Will Be an Overhang for Share Price
Ion Investment (Temasek) is looking to sell about 3.4m shares in Celltrion Inc (068270 KS) in an accelerated bookbuild worth approximately US$740m....
477 Views
Smartkarma’s Week that Was in JP/KR: King Street Vs. Toshiba, Korea's Donki, and SKT Split
Below is the list of the Japan/Korea related posts put on the Smartkarma platform last week. It was a holiday week for both Japan and Korea. So, we...
358 Views
Stub Trade on Samsung C&T with BioLogics as a Sole Pair Partner
The last Samsung C&T (028260 KS) block deals ended last month on Sep 20. C&T is now free of circular shareholding links. That is, C&T...
463 Views